Project Details
Description
A Phase 2, Global, Multicenter, Long-term Safety Study Designed to Assess the Safety and Tolerability of BHV-7000 in Subjects with Refractory Focal Onset Epilepsy
| Status | Active |
|---|---|
| Effective start/end date | 02.10.2024 → 30.06.2026 |
Fields of science
- 302052 Neurology